DUBLIN, Calif., Feb. 26 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid
development and commercialization of therapies for solid tumors and
hematological malignancies, today announced that James S. Manuso, Ph.D.,
President and Chief Executive Officer is scheduled to present at the
Susquehanna SIGnificant Options in Healthcare Conference on March 4, 2008
at the W Hotel in New York.
SuperGen's presentation at the Susquehanna SIGnificant Options in
Healthcare Conference is scheduled to begin at 11:00 a.m. ET. A live
webcast of the presentation will be available on the investor relations
section of the Company's Web site at http://www.supergen.com. The webcast will be
archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company
dedicated to the discovery, rapid development and commercialization of
therapies for solid tumors and hematological malignancies. SuperGen is
developing a number of therapeutic anticancer products focused on kinase
and cell signaling inhibitors and DNA methyltransferase inhibitors. For
more information about SuperGen, please visit http://www.supergen.com.
Contacts
Timothy L. Enns
SuperGen, Inc.
SVP, Corporate Communications & Business Development
Tel: (925) 560-0100
E-mail: tenns@supergen.com
Mary M. Vegh
SuperGen, Inc.
Manager, Investor Relations
Tel: (925) 560-2845
E-mail: mary.vegh@supergen.com
SOURCE SuperGen, Inc.
 back to top
Related links:
http://www.supergen.com
CONTACT:
Timothy L. Enns, SVP, Corporate
Communications & Business Development, +1-925-560-0100,
tenns@supergen.com, or Mary M. Vegh, Manager, Investor Relations,
+1-925-560-2845, mary.vegh@supergen.com, both of SuperGen, Inc.
|
